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Abstract
An attractive approach to replace the destroyed insulin-producing cells (IPCs) is the generation of functional b cells from
stem cells. Embryonal carcinoma (EC) stem cells are pluripotent cells which can differentiate into all cell types. The present
study was carried out to establish a simple nonselective inductive culture system for generation of IPCs from P19 EC cells by
1–2 weeks old mouse pancreas extract (MPE). Since, mouse pancreatic islets undergo further remodeling and maturation for
2–3 weeks after birth, we hypothesized that the mouse neonatal MPE contains essential factors to induce in vitro
differentiation of pancreatic lineages. Pluripotency of P19 cells were first confirmed by expression analysis of stem cell
markers, Oct3/4, Sox-2 and Nanog. In order to induce differentiation, the cells were cultured in a medium supplemented by
different concentrations of MPE (50, 100, 200 and 300 mg/ml). The results showed that P19 cells could differentiate into IPCs
and form dithizone-positive cell clusters. The generated P19-derived IPCs were immunoreactive to proinsulin, insulin and
insulin receptor beta. The expression of pancreatic b cell genes including, PDX-1, INS1 and INS2 were also confirmed. The
peak response at the 100 mg/ml MPE used for investigation of EP300 and CREB1 gene expression. When stimulated with
glucose, these cells synthesized and secreted insulin. Network analysis of the key transcription factors (PDX-1, EP300, CREB1)
during the generation of IPCs resulted in introduction of novel regulatory candidates such as MIR17, and VEZF1
transcription factors, as well as MORN1, DKFZp761P0212, and WAC proteins. Altogether, we demonstrated the possibility of
generating IPCs from undifferentiated EC cells, with the characteristics of pancreatic b cells. The derivation of pancreatic
cells from EC cells which are ES cell siblings would provide a valuable experimental tool in study of pancreatic development
and function as well as rapid production of IPCs for transplantation.
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Introduction
Diabetes mellitus is one of the most common chronic diseases
which directly affects millions of people [1]. Type 1 diabetes can
be ameliorated by islet transplantation. The concept of trans-
planting pieces of pancreas in diabetic patients has over a century
history. However, the major problem is the deficiency of
transplantable cadaver islets. Many studies have been focused on
how to develop renewable sources of islet-replacement tissue.
Whereas some studies have shown the generation of insulin-
producing cells (IPCs) from progenitor cells of the pancreas [2],
liver [3,4], pluripotent embryonic stem (ES) cells [5–9], and skin-
derived stem cells [10], the efficiency of in vitro generated IPCs is
low. The existing protocols for generating IPCs from ES cells can
be divided into spontaneous and induced differentiation [11]. In
the present work, using neonatal mouse pancreas extract (MPE) as
a natural biological inducer, we developed a simple accessible way
to generate functional IPCs from P19 embryonal carcinoma (EC)
stem cell line.
Total removal of the pancreas in dogs produces severe and fatal
diabetes [12]. Daily injections of pancreatic extract prolonged life
of a completely diabetic dog. Subcutaneous administration of
whole pancreas extract to the human subjects caused decrease in
blood sugar and increased utilization of carbohydrate [12].
Experimental studies demonstrated that the supplementation of
oral nutrition with pancreatic extract-enriched diet improved the
nutritional status of the aged rats [13,14]. Reddy et al. showed that
the oral administration of whole pancreas extract to young non-
obese diabetic (NOD) mice, prevented autoimmune diabetes [15].
Rat pancreatic extract (RPE) enhanced the expression of the
required transcription factors for pancreas development [16]. In
vitro differentiation induction of rat mesenchymal cells into IPCs
increased with the treatment of the cells by RPE [17,18]. Using
RPE as a natural biological inducer, Zhang et al. differentiated
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human amniotic mesenchymal stem cells into insulin-secreting
cells [19]. Some studies show that RPE contains various growth
factors and hormones related to pancreas regeneration [20,21].
The effects of RPE on IPCs differentiation of human adipose
tissue-derived stem cells (hASCs) were evaluated. Genes involved
in early pancreas development (such as Sox17 and IPF-1) were
expressed in RPE-treated culture [20].
Information regarding gene co-expression is useful to predict
gene function [22,23]. Several databases have been developed for
gene co-expression analysis based on a large amount of publicly
available gene expression data measured by GeneChip platforms.
DNA microarrays deposited in public databases provide informa-
tion on relative expression levels for thousands of genes
simultaneously. In addition, large collections of microarray data
contain information about concerted changes in transcript levels in
these datasets beyond the original purpose of each dataset. Using
the pattern of gene expression changes between two genes of
interest in these concerted transcripts leads to similarity of
expression (also called as ‘‘gene co-expression’’). The hypothesis
is that, if 2 genes show high correlation in different transcriptomics
experiments/coditions, they are highly correlated to each other
and is expected to show this high correlation in a specific
phenomenon. Commonly, Pearson’s correlation coefficient is used
as a measure of gene co-expression. ‘‘1’’ indicates strong
relationship in an aspect of gene expression regulation, ‘‘0’’
indicates no relationship. In this study, we employed a more recent
expression measure called Mutual Ranking (MR) based on
geometric mean of gene co-expression.
To provide an alternative source of IPCs for injection
treatments, we developed a simple culture system using EC cell
line and neonatal mouse pancreas extract and evaluate the
differentiation of P19 cells into pancreatic b cells in the present
investigation. P19 cells efficiently differentiated into IPCs and
formed pancreatic islet-like structures. The P19-derived IPCs were
immunoreactive to proinsulin, insulin and insulin receptor beta
and could synthesize and secret insulin in response to glucose
challenge. The P19-derived IPCs were also examined for the
expression of the transcription factors which are required for
pancreas development (PDX-1, EP300, CREB1). Network anal-
ysis of these key transcription factors during generation of the IPCs
carried out based on co-expression analysis. Furthermore, to
achieve a more comprehensive view on regulatory mechanisms
governing the generation of IPCs, regulatory networks were
designed by incorporating co-expression analysis results with the
other types of interactions including microRNA inhibitory effect,
promoter binding, and protein modification.
Materials and Methods
Ethics Statement
BALB/c pregnant mice were obtained from Azad University of
Shahrekord (Shahrekord, Iran) and kept under standard housing
conditions. All animal studies were approved by the ethical
committee of Medical Sciences School from Azad University of
Shahrekord, based on the National Specific Ethical Guidelines for
Biomedical Research issued by Ministry of Health and Medicinal
Education (MOHME) of Iran in 2005. Neonatal mice were
anesthetized and then humanely sacrificed using cervical disloca-
tion. All efforts were made to ameliorate suffering in the mice.
Preparation of MPE
Whole pancreas of 1–2 weeks old newborn mice carefully
removed and homogenized in PBS including protease inhibitors
(PMSF, Roche, 10 837 091 001). Homogenates were centrifuged
at 3000 rpm for 10 min at 4uC and then at 12,000 rpm for
20 min, to obtain the final clear supernatant. Immediately after
obtaining the extracts, the samples were taken for analyzing the
protein content using Bradford method. Extract was then stored as
aliquots at 270uC until further use.
Cell culture and differentiation induction protocol
Undifferentiated P19 cells (Pasteur Institute of Iran) were grown
in a-MEM (Minimum Essential Medium, Gibco-BRL, Carlsbad,
CA, 11900073) supplemented with 15% fetal bovine serum (FBS,
Gibco, 10270-106), penicillin (50 mg/ml, Sigma, P3032), and
streptomycin (50 mg/ml, Sigma, S1277) (stage 1). To direct the
differentiation, the cells were grown for 4 days in suspension to
induce embryoid body (EB) formation (stage 2). The EBs were
cultured on 0.1% gelatin-coated petri dishes containing cover slip
in a-MEM supplemented with 3% FBS for an additional 4 days
and then cultured based on either spontaneous or induced
differentiation protocol (stage 3). In order to induce the
differentiation of the cells into IPCs, different concentrations of
MPE (50, 100, 200, and 300 mg/ml) were added in stage 3. The
cells cultured in medium with no MPE were considered as control.
Dithizone (DTZ) staining
Dithizone staining was carried out as previously described [24]
to assess quickly the presence of EC-derived IPCs. Fifty mg of
DTZ (diphenylthiocarbozone, Merck, DX2370-3) in 5 mL of
dimethylsulfoxide (DMSO, Sigma, D2650) was prepared as stock
solution and stored at 220uC. In vitro DTZ staining was
performed by adding 10 mL of the stock solution to 1 mL of
culture medium, and then incubating at 37uC for 15–30 min.
After three times rinsing, the dishes with HBSS (hank’s balanced
salt solution, sodium chloride 8000 mg/l, potassium chloride
400 mg/l, potassium phosphate monobasic KH2PO4 60 mg/l,
glucose 1000 mg/l, sodium phosphate dibasic Na2HPO4 anhyd.
48 mg/l), crimson red stained clusters were examined using a
stereomicroscope. The number of stained cells in the cultures was
counted using a hemocytometer under a microscope using an640
magnification. The assay was repeated at least five times.
Immunoflourescence
The following primary antibodies were used in this study: mouse
monoclonal proinsulin+insulin, (Abcam, ab8304-50) and mouse
monoclonal insulin receptor beta (Abcam, ab8304-100). FITC-
conjugated anti-mouse IgG (Sigma, St. Louis, MO, F9137) was
used as a secondary antibody. Cells were cultured in 6-well plates
on a cover slip, fixed in 4% paraformaldehyde, and permeabilized
with 0.3% Triton X-100 in PBS for 30 min at 37uC. Following
three washes with PBS, the cells were incubated with 10% normal
goat serum (Sigma, G9023) in PBS for 30 min. Afterwards, the
cells were incubated with the relevant primary antibody for
60 min, followed by incubation with the secondary antibody for
30 min. Cover slips were mounted with 70% glycerol in PBS.
Several controls for immunostaining were used, and the primary
antibody was omitted.
Insulin detection assay by enzyme-linked
immunosorbent assay (ELISA)
IPCs, undifferentiated P19 EC cells, and spontaneous differen-
tiated EBs were grown in 6-well plates to estimate the intracellular
and secreted insulin levels by ELISA. Before examination, the cells
were washed three times with PBS and incubated in fresh serum-
free medium with 0.5% bovine serum albumin (BSA) to enable the
detection of insulin secretion without interference from the fetal
Insulin-Producing Cells from Carcinoma Stem Cells
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serum. High-glucose challenge of the cells was achieved by the
addition of serum-free media containing low (5.5 mmol/L)- or
high (25 mmol/L)-glucose for 2 hours at 37uC. The conditioned
media was collected and frozen at 270uC until assayed for insulin
content. For measurement of the intracellular insulin content, cell
pellets were sonicated in acid-ethanol (0.1 N hydrochloric acid in
absolute ethanol). The values obtained were normalized in relation
to the total protein content (protein assay reagent, Bradford,
Sigma, B6916). ELISA was performed on the conditioned media
and cellular extract using insulin mouse ultrasensitive ELISA kit
(Alpco, 80-insmsu-E01).
RNA extraction and real-time RT-polymerase chain
reaction
Total cellular RNA was extracted from IPCs, undifferentiated
P19 EC cells, and spontaneous differentiated EBs using Qiazol
lyses reagent (Qiagene, 79306). Quantiscript reverse transcriptase
(Qiagene -QuantiTect Rev_Transcription Kit, 205311) was used
for synthesis of cDNA with oligo-dT and random primers,
according to the manufacturer’s protocol. RT-PCR assays were
performed using the Qiagen apparatus (Qiagen, Rotor-Gene,
California, USA). Real-time RT-PCRs of undifferentiated stem
cell markers, Oct3/4 (POU Class 5 Homeobox 1), Sox-2 [SRY
(Sex Determining Region Y)-Box 2] and Nanog (Nanog Homeo-
box) [25] as well as pancreatic b cell genes, PDX-1 (pancreatic and
duodenal homeobox 1), INS1 (insulin1), INS2 (insulin2), EP300
(E1A binding protein p300), CREB1 (cAMP responsive element
binding protein 1) and b-2M (b2 microglobulin) cDNAs were
performed by using specific primers (Table 1) and SYBR Premix
Ex Taq (TaKaRa, RR081Q). RT samples and negative controls
(no template) were run together with test samples, and standard
curves were used for each gene tested to analyze the efficiency of
the PCR reaction. A melt curve analysis was performed at the end
of each reaction. Expression levels were normalized to individual
b-2M (internal control). The profile was obtained by plotting
relative gene expression levels comparing to spontaneous differ-
entiated EBs.
Statistical analysis
All experiments were repeated at least three times, and statistical
significances were measured using Student’s t-test, when there
were two groups to be compared and one-way analysis of variance
(ANOVA) and Duncan’s Test, when there were more than two
groups. Results were expressed as the mean 6 standard deviation
(SD) and P,0.05 was considered to be statistically significant.
Co-expression analysis and co-expression-based network
prediction of key IPC-producing TFs (PDX-1, EP300, and
CREB1)
We used recent mutual ranking (MR) index instead of Pearson
correlation coefficient as a co-expression measure by taking a
geometric average of the Pearson correlation coefficient rank from
gene A to gene B and that of gene B to gene A. Obayashi and
Kinoshita, [26] documented that geometric average is a more
accurate mature rather than arithmetic average since the
differences of Pearson correlation coefficient ranks change as
logarithmic manner [26]. In particular, the higher effectiveness of
MR comparing to Pearson correlation coefficient is documented in
large-scale microarray data of different organisms [26].
To perform co-expression analysis, deposited microarray data in
GEO repository of NCBI were used via COXPRESSdb navigator
(http://coxpresdb.jp/) [23]. We also analyzed the list of 100 co-
expressed genes with each of PDX-1, EP300, and CREB1 TFs to
find possible highly co-expressed genes with these TFs. Based on
calculated MRs as a measure of co-expression/relation, co-
expression-based network of PDX-1, EP300, and CREB1 were
constructed.
Regulatory-based (microRNA, literature, promoter
binding) network of PDX-1, EP300, and CREB1
Besides co-expression, genes/proteins can interact to each other
via promoter bonding, microRNA effect, protein modification,
domain-domain interaction to build the network. These types of
relations are the major causes of positive/negative correlation,
signaling and regulatory effects. Using the found co-expressed
genes of previous section as input genes, here, we built and
visualize regulatory networks considering based on mirBase
prediction database and literature mining by Pathway Studio 9
package (Elsevier) as previously described [27]. Statistically
significant subnertworks were also identified by Fisher exact test
implemented in Pathway Studio 9 package [28].
Results
Characterization of P19 EC cells on the basis of cell
morphology and expression of pluripotent markers
The experiments reported here were carried out with the P19
line of murine EC stem cells. At first, the characterization of the
cells was carried out on the basis of cell morphology and
expression of pluripotent markers. Undifferentiated P19 cells were
polygonal in shape. Figure 1 shows the morphology of exponen-
tially growing P19 cells at low (A) and high (B) magnification.
When cultured in gelatinized dishes, the cells formed colonies
composed of tightly packed polygonal cells of small size and
prominent nuclei as presented in Figure 1. In non-adherent
culture, P19 cells formed large spherical cell aggregates known as
EBs. It is in accordance with the expected features of mouse and
human ES cells [29,30]. The EBs were then cultured on 0.1%
gelatin-coated petri dishes containing cover slip. Figure 1 C shows
an attached EB with the cells spread out from it. We also
preformed Real-time PCR for assessing the expression of
Table 1. Real time PCR Primer Sequences.
Gene Primer sequences
PDX-1 F: 59- TCCACCACCACCTTCCAGCTCA -39
R: 59- TTCCTCGGGTTCCGCTGTGT -39
INS1 F: 59- ATGGCCCTGTTGGTGCACTTCC -39
R: 59- AAGAAGCCACGCTCCCCACA -39
INS2 F: 59- AACATGGCCCTGTGGATGCG -39
R: 59- ACCCAGCTCCAGTTGTGCCA -39
EP300 F: 59- TCCATACCGAACAAAGGCCC -39
R: 59- CCAGATGTGCCCTGTTGTGT-39
CREB1 F: 59- AGAAGCAGCACGGAAGAGAG -39
R: 59- CTTTCTGGTTGTGGCCAAGC -39
Oct3/4 F: 59- CTACCATCTGCCGCTTTG-39
R: 59- GCCGCAGCTTACACATGTTCT-39
Sox-2 F: 59- ACAGCAAATGACAGCTGCAAA-39
R: 59- TCGGCATCGCGGTTTTT-39
Nanog F: 59- CCAAAGGCAAACAACCCACTT-39
R: 59- CGGGACCTTGTCTTCCTTTTT-39
b-2M F: 59- AGTCGTCAGCATGGCTCGCT -39
R: 59- TGAGGCGGGTGGAACTGTGT -39
doi:10.1371/journal.pone.0090885.t001
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undifferentiated marker genes, including Oct3/4, Sox-2 and
Nanog. The results showed that the expression of the genes was
positive in P19 cells and significantly down regulated in
differentiated cells (by 23.5, 9, and 4 times, respectively) (see
below).
Morphological studies of differentiated cells
DTZ was used to quickly assess the presence of EC-derived
IPCs. After DTZ staining, IPCs were identified as crimson red cell
clusters. Figure 2 shows the results of DTZ-staining of P19-derived
IPCs (Figure 2 A & B). Distinct DTZ-positive (DTZ+) cell clusters
were observed in MPE-treated P19-derived EB outgrowths, while
they were rare in spontaneous differentiated EBs (Figure 2 C) and
obscure in the intact undifferentiated P19 cultures (Figure 2 D).
To estimate the frequency of the emerged DTZ+ cells in the
cultures, the number of crimson red cells was directly counted
under a microscope. Table 2 shows the percentage of DTZ+ cells
among total cells in different concentrations of MPE. In all MPE-
treated groups, the percentages of DTZ+ cells among total cells
were significantly higher than untreated group. There was also
significant difference between 50-, 100- and 200- and 300- mg/ml
MPE-treated groups (P,0.05).
Detection of pancreatic b cell specific proteins
Immunoflourescence evaluation of the differentiated P19 cells
showed that after MPE treatment these cells were immunoreactive
to proinsulin, insulin (Figure 3 A) and insulin receptor beta
(Figure 3 C). Several controls for immunostaining were used, and
Figure 1. Representative micrographs showing morphology of exponentially growing P19 cells at low (A) and high (B)
magnification. Undifferentiated cells are tightly packed polygonal cells, with large nucleoli and high nucleus–cytoplasm ratio. An embroyid body
replated on 0.1% gelatin coated petri dish (C) differentiated spontaneously or induced by MPE. The cells spread out from the attached EB. Scale bars:
A & C 20 mm, B 10 mm.
doi:10.1371/journal.pone.0090885.g001
Figure 2. DTZ staining of differentiated IPCs, derived from P19 EC cells. IPCs formed pancreatic islet-like structures (A). A cell cluster
distinctly stained crimson red by DTZ is apparent (B). Individual cells are DTZ-positive in spontaneous differentiated EBs (C). Untreated EC cells are not
stained (D). Scale bars: A 100 mm, B, C & D 200 mm.
doi:10.1371/journal.pone.0090885.g002
Insulin-Producing Cells from Carcinoma Stem Cells
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the primary antibody was omitted (Figure 3 E). The same fields
were photographed as phase contrast images (Figure 3 B, D & F).
Insulin secretion and content
Glucose inducible insulin secretion was examined in P19
undifferentiated EC cells, spontaneous differentiated EBs and
IPCs (Figure 4). The statistical differences between the groups used
in the study revealed that compared to P19 and EB, differentiated
IPCs demonstrated increase in secreted (Figure 4 A) and
intracellular insulin (Figure 4 B), when normalized to the total
protein content. Furthermore, when stimulated with glucose, IPCs
synthesized and secreted insulin in a glucose-regulated manner as
presented in Figure 4. Glucose-dependent insulin secretion was not
observed in undifferentiated cells. The insulin secretion and
content significantly enhanced when the glucose concentration in
the medium was increased. The results showed that MPE could
induce dose-dependent P19 differentiation into IPCs.
Quantitative analysis of gene expressions
Real-time qPCR analysis was used to examine the expression of
pancreatic specific genes in differentiated cells. Results from
representative experiments are shown in Figure 5. The data
Table 2. Percentage of DTZ+ cells within total cells in
different concentrations of mouse pancreas extract.






The data present the means 6 standard deviation (SD) of the means of DTZ+
cells derived from P19 EC cells in different concentrations of MPE used in the
study. MPE induced the differentiation of P19 EC cells at a higher mean than
that of the untreated group (0 mg/ml MPE: negative control). MPE: mouse
pancreas extract, DTZ+: DTZ-positive cells.
doi:10.1371/journal.pone.0090885.t002
Figure 3. Fluorescence micrographs illustrating the expression of pancreatic b cell markers. Staining of IPCs with antibodies against
proinsulin+insulin (A) and insulin receptor beta (C) showing that most of the P19 cells treated with MPE express pancreatic b cell markers. (E) Control
for immunostaining, the primary antibody was omitted. B, D & F are phase contrast images of the same field shown in A, C & E respectively. Scale
bars: 40 mm.
doi:10.1371/journal.pone.0090885.g003
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showed that in this culture system, transcription factors essential to
pancreatic development such as PDX-1, INS1, INS2, EP300 and
CREB1 were induced in the differentiated cells. The expression of
PDX-1 was significantly increased in 50, 100 and 200 mg/ml
concentrations of MPE compared with untreated EBs (Figure 5 A).
There is no significant difference between 300 mg/ml of MPE and
EBs in PDX-1 gene expression. MPE also significantly induced
INS1 gene expression at concentration of 50 and 100 mg/ml
(Figure 5 A). No significant differences existed between 200 and
300 mg/ml of MPE and control. Furthermore, the results showed
that the INS2 gene expression was significantly higher at the
concentrations of 100 and 200 mg/ml (Figure 5 A) in comparison
with EBs. There was no significant difference between EB, 50 and
300 mg/ml. The expressions of these three genes were at the
highest level in 100 mg/ml concentration of MPE compared with
all the other groups.
In addition, to characterize the P19 EC cells, a real-time PCR
analysis was performed on these cells and IPCs to compare
undifferentiated marker genes, including Oct3/4, Sox-2 and
Nanog and differentiated cell markers, EP300 and CREB1
(Figure 5 B). The results showed that the expression of Oct3/4,
Sox-2 and Nanog is significantly down regulated in differentiated
cells. EP300 and CREB1 were selected based on the predicted
regulatory network. The expression of these transcription factors
were more highly in IPCs than in P19 EC cells (Figure 5 B).
During differentiation of IPCs from P19 EC, the expression of
EP300 and CREB1 transcription factors was increased by 20 and
7.7 times, respectively. In contrast, a sharp decrease in expression
of Oct3/4, Sox-2, and Nanog was observed by 23.5, 9, and 4
times, respectively (Figure 5 B).
Co-expressed genes with PDX-1, EP300, and CREB1
transcription factors during IPC generation
Co-expressed genes with PDX-1, EP300, and CREB1 tran-
scription factors were identified based on deposited microarray
experiments in NCBI using COXPRESSdb navigator. The first
100 highly co-expressed genes with each of PDX-1, EP300, and
CREB1 transcription factors and their Mutual Correlation Ranks
(MR) are presented in Table S1, Table S2, and Table S3,
respectively.
Interestingly, the two key TFs during IPC generation, EP300
and CREB1, had high level of co-expression in different
microarray experiments where Mutual Correlation Rank was
remarkably low (MR for Hsa ortholog= 5.1, Table S2). This
guaranties highly significant co-expression and co-occurrence of
EP300 and CREB1 during generation of IPC.
Co-expression based network of PDX-1, EP300, and
CREB1 transcription factors
Based on co-expressed genes (selected by MR in different
microarray experiments), expression networks were designed and
visualized by COXPRESSdb (Figure 6). In addition, Functional
annotations of these transcription factors were extracted based on
Biological Process classification of Gene Ontology (Table S4).
As presented in Table S4, comparison of functional annotation
of PDX-1, EP300, and CREB1 shows that PDX-1 has more
glucose/insulin-dependent manner since PDX-1 is involved in GO
groups of detection of glucose, pancreatic b cell differentiation,
exocrine pancreas development, nitric oxide mediated signal
transduction, and endocrine pancreas development. In contrast,
EP300 and CREB1 are more involved in general differentiation
and signaling functional classes such as N-terminal peptidyl-lysine
acetylation, positive regulation of sarcomere organization, positive
regulation of glycoprotein biosynthetic process, Toll signaling
pathway, and positive regulation of transforming growth factor-
beta3 production. The fact that EP300 and CREB1 are highly
coregulated with each other and EP300 has binding sites on
promoter regions of many genes reinforces the hypothesis that
EP300 and CREB1 are shared background of differentiation and
PDX-1 is a specific transcription factor for activation of IPCs
employs. The union network consisting subnetworks activated by
EP300 and CREB1 transcription factors is presented in Figure S1.
The underpining significant subnetworks (p = 0.05) in EP300
CREB1 crosstalk such as neighbors of MAML2, LYL1,
PPP2R5C, POU2F3, CRTC1, SLCO2A1, SIK2, TDG,
PRKAR2B, VRK1, ATF5, and PLAGL1 are in listed Table S7.
The relations and the corresponding references constructing
EP300 CREB1 crosstalk is presented in Table S8.
PDX-1 has significant positive co-expression with MORN1,
DKFZp761P0212, and ROCK1 (Table S4). ROCK1 protein
kinase is a key regulator of actin cytoskeleton and cell
polarity, can phosphorylate many proteins. However,
DKFZp761P0212 is unknown protein and little information
is available for MORN1. Consequently, MORN1 and
DKFZp761P0212 are good targets for future studies regarding
to IPCs generation.
Figure 4. Determination of secreted (A) and secreted versus
intracellular (B) insulin in P19 undifferentiated EC cells (P19),
spontaneous differentiated EBs (EB) and the MPE-treated cells.
Significant insulin concentration was observed in MPE–treated IPCs. To
normalize the amount of insulin secretion, the total protein of the cells
in each well was measured by the Bradford method. The experiment
was performed in triplicate. Each value represents mean 6 SD.
doi:10.1371/journal.pone.0090885.g004
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High co-expression of WAC and VEZF1 with both EP300,
and CREB1 TFs: a potential shared subnetwork during
differentiation
Comparing the commonly coregulated genes with PDX-1,
EP300, and CREB1 transcription factors (Table S1, Table S2, and
Table S3) in different microarray data showed that two genes
WAC (domain containing adaptor with coiled-coil, Entrez Gene
ID: 51322) and VEZF1 (vascular endothelial zinc finger 1, Entrez
Gene ID: 7716) are shared between the first 100 co-expressed
genes with both EP300, and CREB1 transcription factors.
WAC contains a WW domain, which is a protein module found
in a wide range of signaling proteins; however, the exact function
of WAC is not known. Coregulation of WAC, EP300, and CREB1
opens a new avenue in understanding WAC and VEZF1
transcription factor.
Supnetwork analysis of WAC, VEZF1, EP300, and CREB1
unraveled a new regulatory member, MIR17, which negatively
regulates both WAC and EP300 (Figure 7). To get more clues on
WAC function, a regulatory network was constructed based on
literature mining and microRNA prediction which is presented at
Figure 8. The underlying relations of this network are presented in
Table S5. This network shows that WAC is under regulatory
control of NIR17, MIR135B, and MIR135A1. WAC interacts
with splicing factor SC35 (SRSF2) and CDK9 protein kinase.
VEZF1 is a transcriptional regulatory protein containing
tandemly repeated zinc finger domains are thought to be involved
Figure 5. Quantitative analysis of genes involved in differentiation of pancreatic cells derived from P19 EC cells. The cells were
cultured as EBs in different concentrations of MPE (mouse pancreas extract). (A) Relative gene expression of PDX-1, INS1, and INS2 in different
concentration of MPE. (B) Comparison of expression of Oct3/4, Sox-2, Nanog (undifferentiated stem cell markers), and EP300, CREB1 (differentiated
stem cell transcription factors) between P19 EC (embryonal carcinoma) cells and IPCs (insulin-producing cells). The data are expressed as relative gene
expression to b-2M and are presented as mean6SD. The means with different letters are significantly different at P = 0.05.
doi:10.1371/journal.pone.0090885.g005
Figure 6. Co-expression based network of transcription factors involved in generation of insulin producing cells. (A) PDX1, (B) CREB1,
and (C) EP300.
doi:10.1371/journal.pone.0090885.g006
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in both normal and abnormal cellular proliferation and differen-
tiation (http://www.genecards.org/). Designed regulatory network
of VEZF1 transcription factor is presented in Figure 9 and its
underpining relations and references are presented in Table S6.
Architecture of VEZF1 transcription factor unravels an interesting
signaling pathway transferring signal from nerve growth factor
receptor (NGFR) located on cell membrane to nucleus. VEZF1
binds to the CT/GC-rich region of the interleukin-3 promoter and
mediates tax transactivation of IL-3.
Discussion
In the present study, we developed for the first time, a simple,
accessible nonselective way to generate functional IPCs from P19
EC cell line within a short period of time (7–15 days). To induce
IPCs differentiation, MPE from 1–2 weeks mouse neonate was
used as a natural biological inducer. Our findings documented
evidences that P19 cells could differentiate efficiently to functional
IPCs by using MPE. It has been previously shown that pancreas
extract contains various growth factors and hormones [20,21].
Insulin-like growth factors (IGFs), insulin, transforming growth
factor-b (TGF-b) and activin are expressed in the developing
pancreas [31–33]. The exposure of stem cells to growth factors
and extracellular matrix components may promote and streamline
the differentiation process [11]. Since, mouse pancreatic islets
undergo further remodeling and maturation for 2–3 weeks after
birth [34], we hypothesized that the neonatal MPE contains
essential factors to induce in vitro differentiation of pancreatic
lineages. Previous studies showed that RPE which was obtained
after pancreatectomy, could induce pancreas regeneration
[16,20,21] and islet neogenesis in STZ-induced diabetic mice
Figure 7. Crosstalk between highly co-expressed EP300
transcription factors and WAC protein based on MIR17
(microRNA17).
doi:10.1371/journal.pone.0090885.g007
Figure 8. Regulatory network of WAC protein.
doi:10.1371/journal.pone.0090885.g008
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[35]. Moreover, RPE at a final concentration of 200 mg/ml, could
stimulate differentiation of human adipose tissue-derived stem cells
[20] and mesenchymal stem cells [17,18]. Differentiation of
human amniotic mesenchymal stem cells into IPCs by RPE has
been also shown previously [19].
The existing protocols for generating IPCs from ES cells can be
divided into spontaneous and induced differentiation [11]. The
Figure 9. Regulatory network of VEZF1 protein.
doi:10.1371/journal.pone.0090885.g009
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original protocols involve sequential in vitro differentiation steps to
generate nestin expressing cells to derive IPCs from ES cells
[36,37]. However, Kahan et al. described a straightforward,
nonsupplemented, nonselective protocol that supports the differ-
entiation of mouse ES cells toward islet lineages. Their results
indicated that under such spontaneous differentiation conditions,
the cells were capable of differentiating into b like cells [38]. Here,
we developed a simple nonselective inductive culture system rather
than spontaneous differentiation of EC cells. It has been previously
shown that the expansion of nestin-positive cells is not required for
the activation of pancreatic differentiation [37]. Overall, our
observations demonstrated that the differentiation of EC cells
generated islet-like clusters, without selection of nestin-positive
cells. A similar finding was documented by Blyszczuk et al. who
induced ES cells differentiation into IPCs without induction and
selection of nestin-expressing cells [39].
In accord with the earlier works, we demonstrated that MPE
could induce pancreatic markers, proinsulin, insulin and insulin
receptor beta. Expression of proinsulin is the main characteristic
feature of normal pancreatic b cells [40]. Insulin receptor is a
transmembrane receptor that is activated by insulin, IGF-I and
IGF-II. These factors produced by pancreatic islet cells during
development and tissue regeneration. They are strong stimulators
of b cell replication and hypertrophy [41,42]. Although the
components of the MPE were not analyzed in this project,
however, a possibility is that the soluble factors that exist in the
extract were implicated in b cell differentiation via specific
receptors expressed in IPCs.
Our observations documented that P19 cells could differentiate
into functional b cells, capable of producing and secreting insulin
in response to glucose. Both intracellular and secreted insulin
enhanced when the glucose concentration in the medium was
increased. Insulin secretion, especially under glucose induction, is
an essential feature of pancreatic b cells [43]. It should be
emphasized that immunoreactivity for both proinsulin and insulin
in the current study indicated the presence of endogenously
produced insulin. The observation is in line with previous findings
of Fujikawa et al. who claimed that immunoreactivity for
proinsulin or C-peptide indicates that the precursor proinsulin is
synthesized by the differentiated cells [43]. Moreover, intracellular
insulin level after exposure to 25 mM glucose was lower in
comparison to secreted insulin (Figure 4 B). Therefore, it can be
concluded that the hormone produced by the differentiated IPCs
cells rather than taken up from the culture medium.
Real-time PCR analysis confirmed the expression of PDX-1 by
the produced IPCs in our culture system. PDX-1 is a crucial
regulator of pancreatic development [44] and its expression is very
important in the in vitro differentiation of ES cells along
pancreatic cell lineages [45]. Also, we found that mature two
forms of insulin, INS1 and INS2 mRNA both expressed in the
differentiated cells. These findings are in accordance with previous
studies from our laboratory on IPCs differentiation of P19 cells by
pancreas conditioned medium (submitted).
By comparing the expression of stem cell markers, we found
Oct3/4, Sox2 and Nanog were more highly expressed in
undifferentiated P19 cells than in IPCs. These transcription
factors are markers for pluripotency and self-renewal in embryonic
stem cells [46]. Oct3/4 is a POU domain-containing transcription
factor highly expressed in ESCs [27]. Sox-2 is an HMG family
protein which is required for maintenance of ESCs pluripotency
similar to Oct4 [47]. A more recently described gene, Nanog, is
thought to be a new ‘‘master gene’’ of ES cell pluripotency [48].
Functionally, Nanog blocks differentiation; thus, negative regula-
tion of Nanog is required to promote differentiation during
embryonic development [49]. Compared with P19 cells, the
relatively reduced stem cell marker expression in IPCs may
indicate their higher differentiation properties. Thus, it is possible
that when EC cells were cultured as EBs, MPE could increase the
level of specific pancreatic genes, while decreasing the expression
of stem cell markers.
In this study, we used mutual rank (MR) instead of Pearson
correlation coefficient since difference in gene expression corre-
lation commonly follows a logarithmic manner rather than
arithmetic average; consequently, geometric average (MR index)
is more accurate as discussed by Obayashi and Kinoshita [26].
High correlation of EP300 and CREB1 in concert with WAC
and VEZF1 transcriptomics data suggests common key regulators
of differentiation. The fact that EP300 has high correlation with
master transcription factors such as Sp2 transcription factor (Table
S2) which has binding sites on the promoter regions of many genes
reinforces this statement. On the other hand, PDX-1 can be seen
as specific pancreas-development TFs which activates by inducers
of pancreas development (MPE) and in concert with EP300, and
CREB1 activates IPCs generation. The effect of MPE on PDX-1 is
highly significant (p = 0.01) and MPE at 100 (mg/ml) is the best
medium which results in the highest expression of PDX-1
according to Tukey test at p = 0.05 (data not shown).
Conclusion
To best of our knowledge, this is the first report demonstrating
the differentiation of P19 EC cells into IPCs in a simple and
accessible way. By using MPE as a natural inducer, we successfully
differentiated P19 cells into mature islet-like cell clusters with the
molecular and functional characteristics of pancreatic b cells
without selection of nestin-expressing cells. The derivation of
pancreatic cells from EC cells which are ES cell siblings would
provide a valuable experimental tool to study pancreatic
development and function. This method may provide a new way
to substitute the cytokines required in IPCs induction of stem cells.
The current study resulted in new candidates in generation of
IPCs including WAC, VEZF1, MIR17, MORN1, and
DKFZp761P0212 for future studies. All together, bioinformatics
approaches employed in this study helps in discovery of new
elements of insulin-producing cell mechanism and gene discovery
based on network construction.
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